1,000 patients to help unlock secrets of liver surgery recovery
NCT ID NCT07556835
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will follow 1,000 adults who have liver or bile duct surgery at one hospital in Italy. Researchers will track complications, survival, and cancer recurrence for up to 5 years. The goal is to better understand what affects recovery and long-term health after these operations.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better predict surgical risks and long-term outcomes for patients with liver or bile duct diseases.
- What could go wrong
- This is an observational study, not a test of a new treatment. It only collects existing data, so it cannot prove what causes better or worse outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BENIGN LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
San Jacopo Hospital
Pistoia, Tuscany, 51100, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple scan and blood test outsmart liver cancer?
- Can targeted liver chemo turn inoperable tumors into operable ones?
- Could a vaccine help fight Hard-to-Treat cancers?
- Could a tailored diet before surgery boost liver cancer recovery?
- Can a new PET tracer light up hidden cancers?
- Can a new drug outperform standard care for a rare liver disease in teens?